|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pathogenesis and clinical spectrum of primary sclerosing cholangitis显示文摘Primary sclerosing cholangitis(PSC) is a disease of the biliary tract, which has been documented in the literature since 1867. This disease has a strong predilection for affecting men and can be seen in individuals as young as 2 years of age. PSC has a strong associated with inflammatory bowel disease, more commonly with ulcerative colitis, and is also part of the clinical spectrum of Ig G4-related diseases. Smallduct PSC, a variant of PSC, also has an association with inflammatory bowel disease. The exact pathogenesis of PSC is not well understood at present, however, is likely a combination of a genetic predisposition with alteration of the molecular structure of the gut. Abnormal serum liver chemistry and presence of certain autoimmune markers are usually the first indicators leading to a diagnosis of PCS, however, these may often be normal in early stages of this disease. The diagnosis is made by cholangiography, which is now considered the gold standard. PSC is a known pre-malignant condition. Such patients have an increased risk of developing cholangiocarcinoma, gallbladder neoplasia, and colon cancer. Many new treatment modalities have emerged in the recent past, including anti-tumor necrosis factor-α and anti-integrins; however, liver transplantation is the only known cure for PSC. Despite past and present research, PSC remains an enigmatic biliary disease with few viable treatment options. | Neelam G Gidwaney Swati Pawa Kiron M Das | 2017 | World Journal of Gastroenterology2017，23，14： | 4 |
| 2 | ERCP in the management of biliary complications after cholecystectomy显示文摘 | Swati Pawa Firas H. Al-Kawas | 2009 | Current Gastroenterology Reports2009，，2： | 2 |
| 3 | Co - transfer of plasmids in association with conjugative transfer of mupirocin or mupirocin and penicillin resistance in methicillin - resistant Staphylococcus aureus 显示文摘 | Pawa A WC Noble SA Howell | 2000 | J Med Microbiol2000，49，： | 1 |
| 4 | Enhancedrecovery program following colorectal resection in theelderly patient显示文摘 | Pawa N Cathcart PL Arulampalam T H | 2012 | World J Surg2012，36，2： | 1 |
| 5 | Enhanced recovery program following colorectal resection in the elderly patient显示文摘 | Pawa N Cathcart PL Arulampalam TH | 2012 | World J Surg2012，36，2： | 1 |
| 6 | Screening for colorectal cancer:established and emerging modalities显示文摘 | Pawa N Arulampalam T Norton J D | 2011 | Nat Rev Gastroenterol Hepatol2011，8，12： | 1 |
| 7 | Colour Doppler flow ima- ging findings in portal biliopathy 显示文摘 | Gulati G Pawa S Chowdhary V | 2003 | Trop Gastroenterol2003，24，3： | 1 |
| 8 | Does Metformin affect ER, PR, IGF-1R, 13-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer? 显示文摘 | Markowska A Pawa|owska M Filas V | 2013 | Diabetol Metab Syndr2013，5，： | 1 |
| 9 | Endoscopic ultrasound-guided biliary drainage:Are we there yet?显示文摘Endoscopic retrograde cholangiopancreatography(ERCP)is the mainstay procedure of choice for management of obstructive biliary disease.While ERCP is widely performed with high success rates,the procedure is not feasible in every patient such as cases of non-accessible papilla.In the setting of unsuccessful ERCP,endoscopic ultrasound-guided biliary drainage(EUS-BD)has become a promising alternative to surgical bypass and percutaneous biliary drainage(PTBD).A variety of different forms of EUS-BD have been described,allowing for both intrahepatic and extrahepatic approaches.Recent studies have reported high success rates utilizing EUS-BD for both transpapillary and transluminal drainage,with fewer adverse events when compared to PTBD.Advancements in novel technologies designed specifically for EUS-BD have led to increased success rates as well as improved safety profile for the procedure.The techniques of EUS-BD are yet to be fully standardized and are currently performed by highly trained advanced endoscopists.The aim of our review is to highlight the different EUSguided interventions for achieving biliary drainage and to both assess the progress that has been made in the field as well as consider what the future may hold. | Rishi Pawa Troy Pleasant Chloe Tom Swati Pawa | 2021 | World Journal of Gastrointestinal Endoscopy2021，13，8： | 1 |
| 10 | Primary common bile duct closure is safe following emergency and elective exploration显示文摘 | Pawa N Tutton MG | 2009 | World J Surg2009，33，8： | 1 |
| 11 | Does Metformin affect ER,PR,IGF-1R,β-catenin and PAX-2expression in women with diabetes mellitus and endometrial cancer?显示文摘 | Markowska A Pawaowska M Filas V | 2013 | Diabetol Metab Syndr2013，5，1： | 1 |
| 12 | ERCP in the management of biliary com- plications after cholecystectomy 显示文摘 | Pawa S A1-Kawas FH | 2009 | Curt Gastroenterol Rep2009，11，2： | 1 |
| 13 | Boron ameliorates fulminant hepaticfailure by counteracting the changes associated with theoxidative stress显示文摘 | PAWA S ALI S | 2006 | Chemico-Biol Interact2006，160，2： | 1 |
| 14 | Antibiotic resistance among commercially available probiotics显示文摘 | Poonam Sharma Sudhir Kumar Tomar Pawas Goswami Vikas Sangwan Rameshwar Singh | 2014 | Food Research International2014，，： | 1 |
| 15 | Awake laparoscop- ic sleeve gastrectomy under paravertebral and superficial cervical plexus blockade 显示文摘 | A1-Shather H E1-Boghdadly K Pawa A | 2015 | Anaesthesia2015，70，10： | 1 |
| 16 | Boron ameliorates fulminant hepatic failure by counteracting the changes associated with the oxidative stress 显示文摘 | PAWA S ALl S | 2006 | Chemico - Biological Interactions2006，160，2： | 1 |
| 17 | Percuta- neous liver biopsy is safe in chronic hepatitis C patients with end - stage renal disease 显示文摘 | PAWA S EHRINPREIS M MUTCHNICK M | 2007 | Clin Gastroenterol Hepatol2007，5，11： | 1 |
| 18 | ERCP in the management of biliary complications after cholecystectomy显示文摘 | Pawa S Kawas FH | 2009 | Curr Gastroenterol Rep2009，11，2： | 1 |
| 19 | Genetic fuzzy system for damage detection in beams and helicopter rotor blades 显示文摘 | Pawa P M Ganguli R | 2003 | Computer Methods in Applied Mechanics and Engineering2003，192，： | 1 |
| 20 | Artificial intelligence in colonoscopy显示文摘Colorectal cancer remains a leading cause of morbidity and mortality in the United States.Advances in artificial intelligence(AI),specifically computer aided detection and computer-aided diagnosis offer promising methods of increasing adenoma detection rates with the goal of removing more pre-cancerous polyps.Conversely,these methods also may allow for smaller non-cancerous lesions to be diagnosed in vivo and left in place,decreasing the risks that come with unnecessary polypectomies.This review will provide an overview of current advances in the use of AI in colonoscopy to aid in polyp detection and characterization as well as areas of developing research. | Joel Joseph Ella Marie LePage Catherine Phillips Cheney Rishi Pawa | 2021 | World Journal of Gastroenterology2021，27，29： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员